QQ客服 官方微博 反馈留言

	Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization
	Zhu, L.; Liu, R.; Zhang, W.; Qian, S.; Wang, J.
刊名	CLINICAL & TRANSLATIONAL ONCOLOGY
	2018
卷号	20期号:5
关键词	Transcatheter arterial embolization (TAE) Transient hepatic artery ligation (HAL) Hepatocellular carcinoma (HCC) Epidermal growth factor receptor (EGFR) Vascular endothelial growth factor-A (VEGF-A) Stromal cell-derived factor 1 (SDF-1) Slug
ISSN号	1699-048X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3604873
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhu, L.,Liu, R.,Zhang, W.,et al. Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization[J]. CLINICAL & TRANSLATIONAL ONCOLOGY,2018,20(5).
APA	Zhu, L.,Liu, R.,Zhang, W.,Qian, S.,&Wang, J..(2018).Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization.CLINICAL & TRANSLATIONAL ONCOLOGY,20(5).
MLA	Zhu, L.,et al."Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization".CLINICAL & TRANSLATIONAL ONCOLOGY 20.5(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。